🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
IQV
NYSE
🇺🇸 US
IQVIA Holdings Inc.
Healthcare
19Score
DipBuster Score™
$259.32
+$2.015 (+0.78%)
Live price · Source: Yahoo
52-Week Position
$154.50
89% of range
$271.80
Beta
1.186
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta1.186
52W High$271.80
52W Low$154.50
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 89% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position89% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta1.186
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at IQVIA Holdings Inc. (IQV), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-03 | Staub W Richard | SELL | 5,500 |
| 2026-07-31 | Patel Bhavik | SELL | 1,855 |
| 2026-07-29 | Sherbet Eric | SELL | 5,000 |
| 2026-07-29 | Cherofsky Keriann | SELL | 558 |
| 2026-07-29 | Bousbib Ari | SELL | 156,206 |
| 2026-07-29 | Bousbib Ari | SELL | 2,069 |
| 2026-07-29 | Bousbib Ari | SELL | 47,858 |
| 2026-07-29 | Bousbib Ari | SELL | 53,191 |
| 2026-07-29 | Bousbib Ari | SELL | 44,039 |
| 2026-07-29 | Bousbib Ari | SELL | 4,584 |
Valuation
P/E RatioN/A
Market CapN/A
Beta1.186
Dividend/yrNone
52W High$271.80
52W Low$154.50
52-Week Range
$154.50Now$271.80
89% through annual range
From 52W High−4.6%
From 52W Low+67.8%
📖 Plain English Summary
IQVIA Holdings Inc. is at 89% of its 52-week range. Beta 1.186 — moves broadly in line with the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for IQV
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — IQV
Heuristic · balance sheet, insider filings, price data, academic research
IQVIA Holdings Inc. — DipBuster Score 19/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track IQVIA Holdings Inc. free
Add IQV to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
4/25
Momentum & Volume
10/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
1
/100 · NEUTRAL
dip depth
1/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 19/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americ…
Sector
Healthcare
Market
🇺🇸 US
CEO
Ari Bousbib
Staff
94,000 employees
Website